PHARMACY

FDA grants priority review to ViiV drug for HIV

BY Alaric DeArment

LONDON — The Food and Drug Administration has granted priority review to an experimental drug made by ViiV Healthcare for HIV, the company, a joint venture between British drug maker GlaxoSmithKline and American drug maker Pfizer, announced.

The FDA gave the designation to dolutegravir, designed for use in combination with other antiretrovirual drugs in adults and adolescents. The agency gives priority review to drugs that offer significant improvement compared with products already on the market.

The FDA plans to have its review of ViiV’s application finished by Aug. 17.

In other news, the FDA accepted a regulatory filing from GSK and Theravance for the experimental chronic obstructive pulmonary disease drug Anoro (umeclidinium bromide and vilanterol) and plans to have its review finished by Dec. 18.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Gilead voluntarily recalls one lot of injected AIDS-related infection drug

BY Alaric DeArment

FOSTER CITY, Calif. — Drug maker Gilead Sciences has recalled a single lot of an injected drug used to treat an opportunistic infection in AIDS patients due to the presence of foreign matter in some vials, the company said.

Gilead announced the voluntary recall of lot B120217A of Vistide (cidofovir), an injected drug used to treat cytomegalovirus retinitis in patients with AIDS, due to particulate matter.

The company said that it had not received any complaints related to the problem, but that patients risked experiencing serious complications if injected with the particles. The lot was distributed in the United States, Canada and Europe to retail pharmacies, hospitals and wholesalers.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Weis Markets names new VP pharmacy

BY Michael Johnsen

SUNBURY, Pa. —  Weis Markets on Monday promoted Rick Seipp to VP pharmacy. 

In his new position, Seipp will oversee the day-to-day merchandising, operation and management of Weis Markets’ 131 pharmacies. He will also oversee the company’s Lifestyle Initiatives’ team, which focuses on health and wellness issues.  

Seipp will report to Kurt Schertle, EVP sales and merchandising. Prior to his promotion, Seipp was the grocer’s director of pharmacy operations.

Prior to joining Weis in 2010, Seipp worked at Rite Aid. Earlier in his career, he worked as a store level pharmacist, pharmacy manager, pharmacy system development manager and district manager. 

Seipp is a graduate of Wilkes University’s School of Pharmacy and lives in Mechanicsburg, Pa.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?